|
|
|
books
| book details |
Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases
By (author) Michael Kremer, By (author) Rachel Glennerster
|
| on special |
normal price: R 2 478.95
Price: R 2 230.95
|
| book description |
Millions of people in the third world die from diseases that are rare in the first world - diseases like malaria, tuberculosis, and schistosomiasis. AIDS, which is now usually treated in rich countries, still ravages the world's poor. Vaccines offer the best hope for controlling these diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices.;In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: ""Pull"" programs to stimulate research. Here's how such programs to would work. Funding agencies would commit to purchase viable vaccines if and when they were developed. This would create the incentives for vaccine developers to produce usable products for these neglected diseases. Private firms, rather than funding agencies, would pick which research strategies to pursue. After purchasing the vaccine, funders could distribute it at little or no cost to the afflicted countries. Strong Medicine details jus
| product details |
Normally shipped |
Publisher | Princeton University Press
Published date | 27 Sep 2004
Language |
Format | Hardback
Pages | 152
Dimensions | 235 x 152 x 0mm (L x W x H)
Weight | 397g
ISBN | 978-0-6911-2113-0
Readership Age |
BISAC | business & economics / industries / manufacturing industries
| other options |
|
|
|
To view the items in your trolley please sign in.
| sign in |
|
|
|
| specials |
|
|
|
Mason Coile
Paperback / softback
224 pages
was: R 520.95
now: R 468.95
|
A terrifying locked-room mystery set in a remote outpost on Mars.
|
An epic love story with the pulse of a thriller that asks: what would you risk for a second chance at first love?
|
|
|
|
|
